L Rimsky

Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides

L Rimsky, Diane C. Shugars, Thomas J. Matthews · Journal of Virology · 1998 · 421 citations · Full text

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

Jean‐Michel Molina, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2011 · 399 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +8

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Calvin Cohen, Jaime Andrade‐Villanueva, Bonaventura Clotet et al. · The Lancet · 2011 · 369 citations

Treatment And Prevention, Medicine, Human Retrovirus +9

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Hilde Azijn, Ilse Tirry, Johan Vingerhoets et al. · Antimicrobial Agents and Chemotherapy · 2009 · 291 citations · Full text

Hiv-1 Group M, Medicine, Human Retrovirus +15

Cloning and expression of a cDNA for human thioredoxin.

E Wollman, L d'Auriol, L Rimsky et al. · Journal of Biological Chemistry · 1988 · 239 citations · Full text

Protein Expression, Cellular Enzymology, Biochemistry +13